Ifp Advisors, Inc Denali Therapeutics Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$26.28 - $33.92 $394 - $508	15 New	15 $1,000
Q3 2021 Oct 06, 2021	SELL	$48.48 - $78.23 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$50.3 - $78.44 $1,006 - $1,568	-20 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$53.8 - $81.53 $215 - $326	-4 Reduced 16.67%	20 $1,000
Q4 2020 Jan 25, 2021	BUY	$36.89 - $93.56 $332 - $842	9 Added 60.0%	24 $2,000
Q3 2020 Oct 29, 2020	BUY	$23.13 - $38.84 $346 - $582	15 New	15 $1,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.